CT is probably the most widely available imaging technique and has many advantages, especially as a first step in testing a patient with symptoms of a pheochromocytoma or paraganglioma and ...

Solitary adrenal paraganglioma (pheochromocytoma) is excluded, as mutation of succinate dehydrogenase is rarely involved. SDHD >SDHB >SDHC Multiple paragangliomas, at least one of which is in head ...

"Ga-68 DOTATATE PET/CT appears to be the best approach for detecting spinal bone metastases in patients with certain neuroendocrine tumors," the researchers stated. Bone metastases destroy and weaken ...

Dr. William Schaetzel, of Topeka, Kansas, believes Floyd died not from asphyxia from Chauvin’s actions, but from ...

The following is a summary of "Plasma Metanephrines Yield Fewer False-Positive Results Than Urine Metanephrines in Patients With Obstructive Sleep Apnea," published in the March 2024 issue of ...

Lutathera is approved by the US FDA to treat patients aged 12 years and older with rare gastroenteropancreatic neuroendocrine ...

On Saturday, May 11th, from 6:00 – 9:00 p.m., The Clubhouse in East Hampton will host a meaningful fundraiser to the Hamptons ...

The 2004 WHO classification of endocrine tumors defines pheochromocytoma as a tumor arising from catecholamine-producing chromaffin cells in the adrenal medulla -- an intra-adrenal paraganglioma.

Lutathera is the first FDA-approved treatment for younger patients with somatostatin receptor-positive gastroenteropancreatic ...

Lutetium Lu 177 dotatate was approved by the FDA for children aged 12 years and older with somatostatin receptor-positive ...

Lutathera was approved for patients 12 or older with SSTR-positive gastroenteropancreatic neuroendocrine tumors, the FDA ...

Thyroid dysfunction (esp. children 0–3yrs); monitor. Pheochromocytoma or catecholamine-secreting paraganglioma: monitor closely. Homozygous sickle cell disease. History of severe cutaneous ...